N Shen, M Luo, W Gu, M Gong, H Lei, L Bi, C Wang… - Oncogene, 2024 - nature.com
Despite significantly improved clinical outcomes in EGFR-mutant lung adenocarcinoma, all
patients develop acquired resistance and malignancy on the treatment of EGFR tyrosine …